UBS Reiterates Buy Rating on Omega Healthcare Investors (OHI)
Tweet Send to a Friend
UBS analyst Michael Goldsmith reiterated a Buy rating and $54.00 price target on Omega Healthcare Investors (NYSE: OHI).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


